NYUHSL Faculty Bibliography

Searched for:

in-biosketch:true

person:tanejs01

Total Results:

846

Journal of urology. 2016:195(2).DOI: 10.1016/j.juro.2015.10.165

Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) [Comment]

Taneja, Samir S

PMID: 26852973

ISSN: 1527-3792

CID: 2263622

Journal of urology. 2016:195(2):350-1.DOI: 10.1016/j.juro.2015.10.166

Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening [Comment]

Taneja, Samir S

PMID: 26852972

ISSN: 1527-3792

CID: 2263612

Journal of urology. 2016:196(2).DOI: 10.1016/j.juro.2016.05.070

Re: Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: A Prospective Development Study

Taneja, Samir S

PMID: 27479382

ISSN: 1527-3792

CID: 2263842

Journal of urology. 2016:196(4):1124-5.DOI: 10.1016/j.juro.2016.07.067

Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial

Taneja, Samir S

PMID: 27628795

ISSN: 1527-3792

CID: 2263912

Journal of urology. 2016:196(4).DOI: 10.1016/j.juro.2016.07.066

Re: Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker with Outcomes and Survival in Castration-Resistant Prostate Cancer

Taneja, Samir S

PMID: 27628794

ISSN: 1527-3792

CID: 2263902

Journal of urology. 2016:196(4):1123-5.DOI: 10.1016/j.juro.2016.07.065

Re: Reevaluating PSA Testing Rates in the PLCO Trial

Taneja, Samir S

PMID: 27628793

ISSN: 1527-3792

CID: 2263892

Journal of urology. 2016:195(4 Pt 1):926-7.DOI: 10.1016/j.juro.2016.01.053

Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

Taneja, Samir S

PMID: 27302782

ISSN: 1527-3792

CID: 2263752

Journal of urology. 2016:195(4 Pt 1):925-8.DOI: 10.1016/j.juro.2016.01.052

Re: DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Taneja, Samir S

PMID: 27302781

ISSN: 1527-3792

CID: 2263742

Journal of urology. 2016:196(3):743-4.DOI: 10.1016/j.juro.2016.06.069

Re: Expectant Management of Veterans with Early-Stage Prostate Cancer

Taneja, Samir S

PMID: 27597067

ISSN: 1527-3792

CID: 2263882

Journal of urology. 2016:195(4 Pt 1):927-8.DOI: 10.1016/j.juro.2016.01.054

Re: Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-Guided In-Bore Biopsy to MRI-Ultrasound Fusion and Transrectal Ultrasound-Guided Prostate Biopsy in Patients with Prior Negative Biopsies

Taneja, Samir S

PMID: 27302783

ISSN: 1527-3792

CID: 2263762